Initial response to salvage therapy determines prognosis in relapsed pediatric Hodgkin lymphoma patients - Wikidata - wikimedia - TriplyDB

Initial response to salvage therapy determines prognosis in relapsed pediatric Hodgkin lymphoma patients

Initial response to salvage therapy determines prognosis in relapsed pediatric Hodgkin lymphoma patients

http://www.wikidata.org/entity/Q34115831

about

Pediatric Hodgkin lymphoma: biomarkers, drugs, and clinical trials for translational science and medicine.Pediatric Hodgkin lymphoma: trade-offs between short- and long-term mortality risks Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: a report from the Children's Oncology Group A prognostic model predicting autologous transplantation outcomes in children, adolescents and young adults with Hodgkin lymphoma.Prognostic Factors and a New Prognostic Index Model for Children and Adolescents with Hodgkin's Lymphoma Who Underwent Autologous Hematopoietic Stem Cell Transplantation: A Multicenter Study of the Turkish Pediatric Bone Marrow Transplantation Study Children's Oncology Group's 2013 blueprint for research: Hodgkin lymphoma.Stratification of treatment intensity in relapsed pediatric Hodgkin lymphoma.Pretransplant functional imaging and outcome in pediatric patients with relapsed/refractory Hodgkin lymphoma undergoing autologous transplantation.Management of Hodgkins Lymphoma: ICMR Consensus Document.The timing of autologous stem cell transplantation and the prognostic factors affecting the prognosis in children with relapsed Hodgkin lymphoma.Outcome of children and adolescents with recurrent/refractory classical Hodgkin lymphoma, a study from the Société Française de Lutte contre le Cancer des Enfants et des Adolescents (SFCE).Pharmacotherapeutic Management of Pediatric Lymphoma.Outcome of children and adolescents with relapsed Hodgkin lymphoma treated with high-dose therapy and autologous stem cell transplantation: the Memorial Sloan Kettering Cancer Center experience.Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.

P2860

Q30248284-E453EFE0-69AB-46E8-A741-E82DB759E4EB Q34640709-4B289C89-63D7-47E1-BB6F-FBB3466AAF20 Q36025958-3BCB2695-FA07-47E9-A8DC-53F942D21434 Q36248964-6E4CF97D-A743-4CE4-9378-ACD646FEFCEB Q37548240-240C6DFA-759D-473E-8DF8-D3C30447EC6A Q38068839-3BD4FCCB-0BD6-4EE3-80EC-C6E72A712036 Q38185983-8C44FD27-EC35-4B5D-B079-B8ABBD28F915 Q38684561-CBD4CD7D-D5F7-419C-AEC5-2B345959B0CE Q39208309-6678C746-3FD4-4EA8-8AD5-8A964547CC39 Q41265178-951245C2-B985-40F0-89DF-0E02299931CC Q47424276-51162BBC-12BE-4BA9-8DAD-8E0E2F40AA63 Q48321203-627EE74B-5D8E-49E4-B3C1-322E957ACB76 Q48548248-AC965E96-0E2F-4E02-AACF-D669BE09DABA Q51740308-390685D1-20A5-4B35-8241-72472A3F4B19

P2860

Initial response to salvage therapy determines prognosis in relapsed pediatric Hodgkin lymphoma patients

http://www.wikidata.org/entity/Q34115831

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Initial response to salvage th ...... tric Hodgkin lymphoma patients

@ast

Initial response to salvage th ...... tric Hodgkin lymphoma patients

@en

Initial response to salvage th ...... tric Hodgkin lymphoma patients

@nl

type

label

Initial response to salvage th ...... tric Hodgkin lymphoma patients

@ast

Initial response to salvage th ...... tric Hodgkin lymphoma patients

@en

Initial response to salvage th ...... tric Hodgkin lymphoma patients

@nl

prefLabel

Initial response to salvage th ...... tric Hodgkin lymphoma patients

@ast

Initial response to salvage th ...... tric Hodgkin lymphoma patients

@en

Initial response to salvage th ...... tric Hodgkin lymphoma patients

@nl

P1433

Q34115831-0225B383-6874-476C-8F14-3C3FFA8DC1CF

P1476

Q34115831-21E25BFF-9093-4289-961C-437416AAF962

P2093

Q34115831-07838DF5-03BC-44A6-BCA0-2B41931674E7

Q34115831-15BE823C-DC41-4A24-AA32-50EFD57F169B

Q34115831-1BCFC9C8-A8AB-42FD-B89B-9BA43BDB5C87

Q34115831-1ED4CE73-729A-468E-A895-B01D87C5A8B6

Q34115831-99A8E923-E9A9-4E0E-9048-71395AEA24A0

Q34115831-9EF80529-CA11-485B-AAFE-66605BED5492

Q34115831-EC07175B-CCDE-4148-A92D-DE9A098CAF15

Q34115831-EDD3DB94-DA36-4821-BBEE-4C18593CE058

P2860

Q34115831-2145B101-A3DA-4218-887B-88663AE11068

Q34115831-3D57A67B-69BC-489E-A837-FB7DF95DCB99

Q34115831-42F36114-35AC-4D25-98B3-6372898C7696

Q34115831-43379AD6-6C00-4EB2-A4A1-C9BF9859BF96

Q34115831-44221163-087E-4F66-A3CD-DC7CA0D9376A

Q34115831-55C3B048-4A6B-47F4-9905-91EADACC4A7C

Q34115831-6021E35E-ACB1-4817-AF1A-A6310DF60AAA

Q34115831-6226B568-4AF9-4AEA-B82B-6FD5C989816A

Q34115831-689575AB-417B-433A-9EE5-1DD31A3945BD

Q34115831-7BA01366-A7B5-44D6-A6DE-FBFA5AEED5B2

P304

Q34115831-54315090-F124-42EF-B404-322B3CF9EEBE

P31

Q34115831-B5DD1760-4412-4AFD-8E20-7F57B42B7286

P356

Q34115831-79F5BEA8-BB68-4E02-A351-97E4A9C14E33

P407

Q34115831-3428EBEA-676D-4ACF-AC64-9B1BBFD5EE87

P433

Q34115831-9D194F2A-39B0-45BC-9B36-0E161A932F63

P478

Q34115831-6B198E6D-3368-42D9-8B4D-0FA54BB66D40

P577

Q34115831-9BDA9257-30B4-498C-A10B-0A20EB5F8C46

P5875

Q34115831-C1ABD0A7-018C-4314-AEDE-A273CE888A20

P698

Q34115831-1645804E-FCE6-40AD-9436-96CAF2799394

P932

Q34115831-CB7B9A49-7A85-4444-8D35-C85B2B23E24F

P356

P1433

P1476

Initial response to salvage th ...... tric Hodgkin lymphoma patients

@en

P2093

Jianrong Wu

http://www.w3.org/2001/XMLSchema#string

John T Sandlund

http://www.w3.org/2001/XMLSchema#string

Larry E Kun

http://www.w3.org/2001/XMLSchema#string

Matthew J Krasin

http://www.w3.org/2001/XMLSchema#string

Melissa M Hudson

http://www.w3.org/2001/XMLSchema#string

Monika L Metzger

http://www.w3.org/2001/XMLSchema#string

Scott C Howard

http://www.w3.org/2001/XMLSchema#string

Sue C Kaste

http://www.w3.org/2001/XMLSchema#string

P2860

Report of the Committee on Hodgkin's Disease Staging Classification

Stanford V and radiotherapy for locally extensive and advanced Hodgkin's disease: mature results of a prospective clinical trial.

VAMP and low-dose, involved-field radiation for children and adolescents with favorable, early-stage Hodgkin's disease: results of a prospective clinical trial.

A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease.

Aggressive conventional chemotherapy compared with high-dose chemotherapy with autologous haemopoietic stem-cell transplantation for relapsed chemosensitive Hodgkin's disease: a randomised trial.

Prognostic factors and treatment outcome in patients with primary progressive and relapsed Hodgkin's disease.

Favorable outcome of patients with relapsed or refractory Hodgkin's disease treated with high-dose chemotherapy and stem cell rescue at the time of maximal response to conventional salvage therapy (Dex-BEAM).

Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed?

Pediatric hodgkin lymphoma: maximizing efficacy and minimizing toxicity.

High-dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial.

P304

4376-4384

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.25225

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

116

http://www.w3.org/2001/XMLSchema#string

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

44689303

http://www.w3.org/2001/XMLSchema#string

P698

20564743

http://www.w3.org/2001/XMLSchema#string

P932

2936658

http://www.w3.org/2001/XMLSchema#string